Specification:
It recognizes a cell surface glycoprotein of 95/115/135kDa (depending upon the extent of glycosylation), identified as CD43. 70-90% if T-cell lymphomas and from 22-37% of B-cell lymphomas express CD43. No reactivity has been observed with reactive B-cells. So a B-lineage population that co-expresses CD43 is highly likely to be malignant lymphoma, especially a low grade lymphoma, rather than a reactive B-cell population. When CD43 antibody is used in combination with anti-CD20, effective immunophenotyping of the lymphomas in formalin-fixed tissues can be obtained. Co-staining of a lymphoid infiltrate with anti-CD20 and anti-CD43 argues against a reactive process and favors a diagnosis of lymphoma.
Immunogen:
Recombinant full-length human SPN protein
Presentation:
Purified antibody from bioreactor concentrates by protein A/G. Prepared in 10mM PBS with 0.05% BSA and 0.05% Azide.
دیدگاهها
هیچ دیدگاهی برای این محصول نوشته نشده است.